Is Moderna Stock Overvalued?
Moderna (NASDAQ: MRNA) ranks as one of the biggest winners of the coronavirus vaccine race. The stock has skyrocketed, but has it gone up too much? In this Motley Fool Live video recorded on Jan. 6, 2021, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights discuss whether or not Moderna is overvalued after its impressive run.
Source Fool.com